🧪 Hypotheses

therapeutic 0.96

Closed-loop transcranial focused ultrasound targeting EC-II SST interneurons to restore hippocampal gamma oscillations v

🧬 SST 🏥 Alzheimer's disease 📖 50🏛 3

✅ 0.00 ✨ 0.60 💥 0.00

## Mechanistic Overview...

therapeutic 0.95

Closed-loop optogenetic targeting PV interneurons to restore theta-gamma coupling and prevent amyloid-induced synaptic d

🧬 PVALB 🏥 Alzheimer's disease 📖 50🏛 3

✅ 0.00 ✨ 0.50 💥 0.00

## Mechanistic Overview...

therapeutic 0.91

Closed-loop transcranial focused ultrasound to restore hippocampal gamma oscillations via cholecystokinin interneuron ne

🧬 CCK 🏥 Alzheimer's disease 📖 50🏛 2

✅ 0.00 ✨ 0.64 💥 0.00

## Mechanistic Overview...

therapeutic 0.90

Gamma entrainment therapy to restore hippocampal-cortical synchrony

🧬 SST 🏥 Alzheimer's disease 📖 57🏛 2

✅ 0.88 ✨ 0.78 💥 0.80

## Mechanistic Overview...

therapeutic 0.88

APOE-Dependent Autophagy Restoration

🧬 MTOR 🏥 neurodegeneration 📖 44🏛 3

✅ 0.90 ✨ 0.60 💥 0.80

## Mechanistic Overview...

therapeutic 0.87

Hippocampal CA3-CA1 synaptic rescue via DHHC2-mediated PSD95 palmitoylation stabilization

🧬 BDNF 🏥 Alzheimer's disease 📖 1🏛 3

✅ 0.70 ✨ 0.82 💥 0.83

## Mechanistic Overview...

therapeutic 0.87

Optogenetic restoration of hippocampal gamma oscillations via selective PV interneuron activation using implantable LED

🧬 PVALB 🏥 Alzheimer's disease 📖 57🏛 3

✅ 0.45 ✨ 0.78 💥 0.68

## Mechanistic Overview...

therapeutic 0.86

Closed-loop focused ultrasound targeting EC-II PV interneurons to restore theta-gamma coupling and prevent tau seeding i

🧬 PVALB 🏥 Alzheimer's disease 📖 59🏛 3

✅ 0.45 ✨ 0.85 💥 0.75

## Mechanistic Overview...

therapeutic 0.86

Circadian Glymphatic Entrainment via Targeted Orexin Receptor Modulation

🧬 HCRTR1/HCRTR2 🏥 neurodegeneration 📖 27🏛 2

✅ 0.90 ✨ 0.75 💥 0.80

## Mechanistic Overview...

therapeutic 0.85

Senescent Cell ASM-Complement Cascade Intervention

🧬 SMPD1 🏥 neurodegeneration 📖 42🏛 1

✅ 0.68 ✨ 0.78 💥 0.75

## Mechanistic Overview...

therapeutic 0.85

Closed-loop tACS targeting EC-II parvalbumin interneurons to restore gamma rhythmogenesis and block tau AIS disruption i

🧬 PVALB 🏥 Alzheimer's disease 📖 50🏛 2

✅ 0.86 ✨ 0.79 💥 0.80

## Mechanistic Overview...

therapeutic 0.85

Beta-frequency entrainment therapy targeting PV interneuron-astrocyte coupling for tau clearance

🧬 SST 🏥 Alzheimer's disease 📖 50🏛 2

✅ 0.85 ✨ 0.82 💥 0.82

## Mechanistic Overview...

therapeutic 0.84

Neutral Sphingomyelinase-2 Inhibition for Synaptic Protection in Neurodegeneration

🧬 SMPD3 🏥 neurodegeneration 📖 36🏛 1

✅ 0.68 ✨ 0.78 💥 0.75

## Mechanistic Overview...

therapeutic 0.83

Real-time gamma-guided transcranial focused ultrasound targeting EC-II SST interneurons to restore hippocampal-prefronta

🧬 SST 🏥 Alzheimer's disease 📖 50🏛 3

✅ 0.35 ✨ 0.82 💥 0.78

## Mechanistic Overview...

therapeutic 0.83

Closed-loop transcranial focused ultrasound to restore hippocampal gamma oscillations via glymphatic enhancement and amy

🧬 PVALB 🏥 Alzheimer's disease 📖 65🏛 2

✅ 0.55 ✨ 0.82 💥 0.78

## Mechanistic Overview...

therapeutic 0.82

AMPK hypersensitivity in astrocytes creates enhanced mitochondrial rescue responses

🧬 PRKAA1 🏥 neurodegeneration 📖 41🏛 2

✅ 0.85 ✨ 0.80 💥 0.75

## Mechanistic Overview...

therapeutic 0.82

Hippocampal CA3-CA1 circuit rescue via neurogenesis and synaptic preservation

🧬 BDNF 🏥 Alzheimer's disease 📖 77🏛 2

✅ 0.72 ✨ 0.68 💥 0.78

## Mechanistic Overview...

therapeutic 0.81

Extracellular Vesicle Biogenesis Modulation

🧬 CHMP4B 🏥 neurodegeneration 📖 7🏛 1

✅ 0.35 ✨ 0.63 💥 0.00

## Mechanistic Overview...

therapeutic 0.81

LRP1-Dependent Tau Uptake Disruption

🧬 LRP1 🏥 neurodegeneration 📖 9🏛 1

✅ 0.29 ✨ 0.35 💥 0.00

## Mechanistic Overview...

therapeutic 0.81

Beta-Hydroxybutyrate Receptor (HCAR2) Signaling Links Ketone Deficiency to Neuroinflammation

🧬 HCAR2 🏥 neurodegeneration 📖 11🏛 1

✅ 0.82 ✨ 0.70 💥 0.75

## Mechanistic Overview...

therapeutic 0.81

Neutrophil Extracellular Trap (NET) Inhibition

🧬 PADI4 🏥 N/A 📖 10🏛 1

✅ 0.00 ✨ 0.41 💥 0.00

## Mechanistic Overview...

therapeutic 0.80

Dual-Receptor Antibody Shuttling

🧬 N/A 🏥 Alzheimer's disease 📖 10🏛 1

✅ 0.55 ✨ 0.34 💥 0.00

## Mechanistic Overview...

therapeutic 0.80

Microglial TREM2-SYK Pathway Enhancement

🧬 TREM2 🏥 neurodegeneration 📖 8🏛 1

✅ 0.70 ✨ 0.60 💥 0.80

## Mechanistic Overview...

therapeutic 0.80

Closed-loop transcranial focused ultrasound targeting CA1 PV interneurons with real-time gamma feedback to prevent tau p

🧬 PVALB 🏥 Alzheimer's disease 📖 50🏛 2

✅ 0.35 ✨ 0.92 💥 0.78

## Mechanistic Overview...

therapeutic 0.79

Senescent Microglia Resolution via Maresins-Senolytics Combination

🧬 BCL2L1 🏥 neurodegeneration 📖 25🏛 2

✅ 0.70 ✨ 0.80 💥 0.80

## Mechanistic Overview...

therapeutic 0.79

Selective TLR4 Modulation to Prevent Gut-Derived Neuroinflammatory Priming

🧬 TLR4 🏥 neurodegeneration 📖 45🏛 3

✅ 0.80 ✨ 0.70 💥 0.70

## Mechanistic Overview...

therapeutic 0.79

VCP-Mediated Autophagy Enhancement

🧬 VCP 🏥 neurodegeneration 📖 17🏛 1

✅ 0.64 ✨ 0.37 💥 0.00

## Mechanistic Overview...

therapeutic 0.78

Closed-loop tACS targeting entorhinal cortex layer II SST interneurons to activate AMPK-autophagy flux and degrade intra

🧬 SST 🏥 Alzheimer's disease 📖 58🏛 2

✅ 0.00 ✨ 0.66 💥 0.00

## Mechanistic Overview...

therapeutic 0.78

Selective HDAC3 Inhibition with Cognitive Enhancement

🧬 HDAC3 🏥 neurodegeneration 📖 48🏛 3

✅ 0.70 ✨ 0.85 💥 0.80

## Mechanistic Overview...

therapeutic 0.78

APOE4-Specific Proteolytic Fragment Inhibition Therapy

🧬 APOE 🏥 Alzheimer's disease 📖 31🏛 1

✅ 0.45 ✨ 0.80 💥 0.70

## Mechanistic Overview...